Socio demographic characteristics of respondents (n = 259). by Isha Aryal (22582068)

Subjects:

Association between mental health status and socio-demographic variables of respondents (n = 259). by Isha Aryal (22582068)

Subjects:

Correlation of screen time with sleep quality and mental health score. by Isha Aryal (22582068)

Subjects:

Association between screen time and demographic variables of respondents (n = 259). by Isha Aryal (22582068)

Subjects:

Association of screen time variables with mental health of respondents (n = 259). by Isha Aryal (22582068)

Subjects:

Association of screen time variables with sleep quality of respondents (n = 259). by Isha Aryal (22582068)

Subjects:

Frequency and percentage on screen time questionnaire of respondents (n = 259). by Isha Aryal (22582068)

Subjects:

PLE inhibits IMQ-induced inflammatory in mice, and the contents of TNF-α (A) and IL-17A (B). by Xiaoqiang Huang (1457860)

Mean plasma concentration-time profiles of paeoniflorin and paeonol comparing low and high repeated doses of MC in DNBS-induced colitis rats. by Jin-Hwa Kim (101817)

Changes associated with kidney fibrosis and effects of MN705 treatment on TGF- by Wencheng Jin (13136262)

Aβ and vGlut2 staining of 6-, 9-, and 12-month dLGN sections show significant plaque load and accelerated loss of retinal ganglion cell axon terminals in the 5xFAD mice. by Shaylah McCool (20818280)

Genes with highest fold change in exponential compared to stationary phase. Genes with >10 fold enrichment are shown, ribosomal genes are highlighted with bolded text. <i>rpsJ</i>/... by Justin Greene (306625)

Subjects:

Changes related to kidney staining in UUO mouse model. by Wencheng Jin (13136262)

Changes associated with kidney fibrosis in TGF- by Wencheng Jin (13136262)

The screening process of MN705. by Wencheng Jin (13136262)

Validation of MN705 treatment effects in human proximal tubular epithelial cells during TGF- by Wencheng Jin (13136262)

Effect of MN705 treatment on TGF- by Wencheng Jin (13136262)

Renal (urea and creatinine) (a, b) and Liver function (ALT and AST) (c, d) test in serums of different experimental groups and body weight changes (e) on day 10. by Omid Mehrpour (9385929)

The characteristics and clinical features of 12 patients. by Masashi Okawa (8951294)

Subjects:

Effect of the VEGF-A–bevacizumab complex removal using immunoprecipitation on the concentrations of VEGF-A121, VEGF-A165, and VEGF-A. by Masashi Okawa (8951294)

Subjects: